THC and CBD reduce inflammation after bone marrow transplant in mice but slow immune recovery

Cannabinoids reduced graft-versus-host disease severity and improved survival in transplanted mice, but also inhibited lymphocyte recovery, creating a double-edged therapeutic challenge.

Khuja, Iman et al.·International journal of molecular sciences·2019·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-02107Animal StudyPreliminary Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

In an allogeneic transplant model, THC-high and CBD-high cannabis extracts reduced GVHD severity and improved survival better than pure cannabinoids. However, both THC and CBD inhibited lymphocyte reconstitution in syngeneic models, with CB2 receptor involvement confirmed.

Key Numbers

Cannabis extracts (THC-high and CBD-high) significantly improved survival in the allogeneic model compared to pure THC or CBD alone.

How They Did This

Researchers compared THC, CBD, and cannabis extracts in vitro lymphocyte assays and in two mouse bone marrow transplant models (syngeneic and allogeneic), measuring immune reconstitution, GVHD severity, and survival.

Why This Research Matters

Bone marrow transplant patients often use cannabis for symptom relief. This study reveals a tradeoff: cannabinoids may reduce harmful inflammation (GVHD) but could also slow the immune recovery that transplant patients desperately need.

The Bigger Picture

The finding that whole cannabis extracts outperformed pure compounds in vivo adds to growing evidence of an entourage effect. The simultaneous immune suppression and GVHD reduction illustrates the complexity of cannabinoid immunology.

What This Study Doesn't Tell Us

Mouse models only. Dosing regimens may not translate to human transplant patients. The study did not test different timing strategies that might preserve anti-GVHD benefits while minimizing immune suppression.

Questions This Raises

  • ?Could timed cannabinoid administration (post-engraftment only) preserve GVHD protection without impairing early immune recovery?
  • ?Do these findings extend to human bone marrow transplant patients?

Trust & Context

Key Stat:
Extracts outperformed pure compounds
Evidence Grade:
Preliminary: mouse study only, no human data.
Study Age:
Published in 2019.
Original Title:
Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation.
Published In:
International journal of molecular sciences, 20(3) (2019)
Database ID:
RTHC-02107

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Should bone marrow transplant patients use cannabis?

This mouse study found cannabinoids reduced transplant complications but also slowed immune recovery. The tradeoffs have not been studied in humans.

Did whole cannabis extracts work better than pure THC or CBD?

Yes, in the allogeneic transplant model, THC-high and CBD-high extracts reduced GVHD severity and improved survival significantly better than pure cannabinoids.

Read More on RethinkTHC

Cite This Study

RTHC-02107·https://rethinkthc.com/research/RTHC-02107

APA

Khuja, Iman; Yekhtin, Zhanna; Or, Reuven; Almogi-Hazan, Osnat. (2019). Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation.. International journal of molecular sciences, 20(3). https://doi.org/10.3390/ijms20030668

MLA

Khuja, Iman, et al. "Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation.." International journal of molecular sciences, 2019. https://doi.org/10.3390/ijms20030668

RethinkTHC

RethinkTHC Research Database. "Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Reco..." RTHC-02107. Retrieved from https://rethinkthc.com/research/khuja-2019-cannabinoids-reduce-inflammation-but

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.